Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues:
Premiums		$ 1,145	$ 1,210	$ 3,422	$ 3,486
Net investment income		783	778	2,357	2,345
Net investment gains (losses)		(51)	(27)	(59)	(11)
Insurance and investment product fees and other		223	229	672	680
Total revenues		2,100	2,190	6,392	6,500
Benefits and expenses:
Benefits and other changes in policy reserves		1,290	1,934	3,714	4,282
Interest credited		179	185	540	552
Acquisition and operating expenses, net of deferrals		314	284	876	839
Amortization of deferred acquisition costs and intangibles		563	113	759	325
Goodwill impairment		0	550	0	550
Interest expense		105	104	315	327
Total benefits and expenses		2,451	3,170	6,204	6,875
Income (loss) from continuing operations before income taxes		(351)	(980)	188	(375)
Provision (benefit) for income taxes		(134)	(187)	27	(16)
Income (loss) from continuing operations		(217)	(793)	161	(359)
Income (loss) from discontinued operations, net of taxes		(21)	6	(334)	19
Net loss		(238)	(787)	(173)	(340)
Less: net income attributable to noncontrolling interests		46	57	150	144
Net loss available to Genworth Financial, Inc.'s common stockholders		$ (284)	$ (844)	$ (323)	$ (484)
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		$ (0.53)	$ (1.71)	$ 0.02	$ (1.01)
Diluted		(0.53)	(1.71)	0.02	(1.01)
Net loss available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		(0.57)	(1.70)	(0.65)	(0.98)
Diluted		$ (0.57)	$ (1.70)	$ (0.65)	$ (0.98)
Weighted-average common shares outstanding:
Basic		497.4	496.6	497.3	496.4
Diluted	[1]	497.4	496.6	499.0	496.4
Supplemental disclosures:
Total other-than-temporary impairments		$ (10)	$ (13)	$ (13)	$ (16)
Portion of other-than-temporary impairments included in other comprehensive income (loss)		1	7	1	7
Net other-than-temporary impairments		(9)	(6)	(12)	(9)
Other investments gains (losses)		(42)	(21)	(47)	(2)
Net investment gains (losses)		$ (51)	$ (27)	$ (59)	$ (11)

[1] Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and the three and nine months ended September 30, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2015 and the three and nine months ended September 30, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 1.3 million, 5.4 million and 6.4 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and the three and nine months ended September 30, 2014, dilutive potential weighted-average common shares outstanding would have been 498.7 million, 502.0 million and 502.8 million, respectively.